Inheritance of susceptibility to induction of nephroblastomas in the Noble rat.
Noble (Nb) strain rats are susceptible to nephroblastoma induction with transplacental exposure to direct-acting alkylating agent N-nitrosoethylurea (ENU), while F344 strain rats are highly resistant. To study the inheritance of susceptibility to induction of these embryonal renal tumors, fetal Nb and F344 rats and F1, F2 and reciprocal backcross hybrids were exposed transplacentally to ENU once on day 18 of gestation. Nephroblastomas developed in 53% of Nb offspring with no apparent gender difference, while no nephroblastomas developed in inbred F344 offspring. F1 and F2 hybrid offspring had intermediate responses, 28% and 30%, respectively. Nephroblastoma incidence in the offspring of F1 hybrids backcrossed to the susceptible strain Nb was 46%, while that in F1 hybrids backcrossed to resistant strain F344 was much lower (16%). Carcinogenic susceptibility is therefore consistent with the involvement of one major autosomal locus; the operation of a gene dosage effect; and a lack of simple Mendelian dominance for either susceptibility or resistance. Since established Wilms tumor-associated suppressor genes, Wt1 and Wtx, were not mutated in normal or neoplastic tissues, genomic profiling was performed on isolated Nb and F344 metanephric progenitors to identify possible predisposing factors to nephroblastoma induction. Genes preferentially elevated in expression in Nb rat progenitors included Wnt target genes Epidermal growth factor receptor, Inhibitor of DNA binding 2, and Jagged1, which were further increased in nephroblastomas. These studies demonstrate the value of this model for genetic analysis of nephroblastoma development and implicate both the Wnt and Notch pathways in its pathogenesis.
Diwan
Bhalchandra A
BA
Basic Research Program, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, Frederick, MD 21702, USA.
Timofeeva
Olga
O
Rice
Jerry M
JM
Yang
Yili
Y
Sharma
Nirmala
N
Fortini
Mark E
ME
Wang
Honghe
H
Perantoni
Alan O
AO
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D015153:Blotting, Western; D001947:Breeding; D005038:Ethylnitrosourea / Q000494:pharmacology; D005260:Female; D020869:Gene Expression Profiling; D020022:Genetic Predisposition to Disease; D007668:Kidney / Q000187:drug effects; D007680:Kidney Neoplasms / Q000235:genetics* / Q000503:physiopathology; D008297:Male; D009154:Mutation; D051381:Rats; D011919:Rats, Inbred Strains; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction; D025521:Tumor Suppressor Proteins / Q000235:genetics; D025721:WT1 Proteins / Q000235:genetics; D009396:Wilms Tumor / Q000235:genetics* / Q000503:physiopathology
D000477:Alkylating Agents; D025521:Tumor Suppressor Proteins; D025721:WT1 Proteins; D005038:Ethylnitrosourea